liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia
Skåne University Hospital, Sweden; Lund University, Sweden.
Skåne University Hospital, Sweden.
University of and Regional Labs Regional Skåne, Sweden; Lund University, Sweden.
Linköping University, Department of Clinical and Experimental Medicine, Division of Clinical Sciences. Region Östergötland, Center for Surgery, Orthopaedics and Cancer Treatment, Department of Haematology. Linköping University, Faculty of Health Sciences.
Show others and affiliations
2015 (English)In: European Journal of Haematology, ISSN 0902-4441, E-ISSN 1600-0609, Vol. 94, no 5, 419-423 p.Article in journal (Refereed) Published
Abstract [en]

Unsuccessful cytogenetics (UC) in patients with acute myeloid leukaemia (AML) treated on different SWOG trials was recently reported to be associated with increased age and dismal outcome. To ascertain whether this holds true also in unselected patients with AML, we retrieved all cytogenetic reports in cases from the population-based Swedish AML Registry. Between 1997 and 2006, 1737 patients below 80yr of age without myelosarcoma or acute promyelocytic leukaemia received intensive treatment. The frequencies of UC and unperformed cytogenetics (UPC) were 2.1% and 20%, respectively. The early death rates differed between the cytogenetic subgroups (P=0.006) with the highest rates in patients with UC (14%) and UPC (12%) followed by high-risk (HR) AML, intermediate risk (IR) and standard risk (SR) cases successfully karyotyped (8.6%, 5.9%, and 5.8%, respectively). The complete remission rate was lower in UC and UPC and HR compared with the other risk groups (Pless than0.001). The overall five-year survival rates were 25% for UC and 22% for UPC, whereas the corresponding frequencies for SR, IR and HR AML patients without UC and UPC were 64%, 31% and 15%, respectively. In conclusion, lack of cytogenetic data translates into a poor prognosis.

Place, publisher, year, edition, pages
Wiley: 12 months , 2015. Vol. 94, no 5, 419-423 p.
Keyword [en]
unsuccessful metaphase analysis; unperformed cytogenetics; acute myeloid leukaemia; karyotype; survival
National Category
Clinical Medicine
Identifiers
URN: urn:nbn:se:liu:diva-117785DOI: 10.1111/ejh.12446ISI: 000352633000007PubMedID: 25200361OAI: oai:DiVA.org:liu-117785DiVA: diva2:811281
Note

Funding Agencies|Swedish Cancer Society; Swedish Research Council; Regional Cancer Centers; Swedish Association of Local Authorities and Regions (SKL)

Available from: 2015-05-11 Created: 2015-05-08 Last updated: 2015-05-11

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Antunovic, Petar
By organisation
Division of Clinical SciencesDepartment of HaematologyFaculty of Health Sciences
In the same journal
European Journal of Haematology
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 26 hits
ReferencesLink to record
Permanent link

Direct link